[1]Ruiz-Calero Cendrero RM, Cancho Castellano B, Martín Hidalgo-Barquero MV, et al.When can it be useful to look for occult HBV in hemodialysis patients?[J].Nefrologia, 2020, 40(2):115-119
[2]Zhao X, Niu Q, Gan L, et al.Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Sci Rep, 2021, 11(1)
[3]Kwak MS, Kim YJ.Occult hepatitis B virus infection[J].World J Hepatol, 2014, 6(12):860-869
[4]Raimondo G, Locarnini S, Pollicino T, et al.Update of the statements on biology and clinical impact of occult hepatitis B virus infection[J].J Hepatol, 2019, 71(2):397-408
[5]Makvandi M.Update on occult hepatitis B virus infection[J].World J Gastroenterol, 2016, 22(39):8720-8734
[6]Fontenele AM, Filho NS, Ferreira AS.Occult hepatitis B in patients on hemodialysis: a review[J].Ann Hepatol, 2013, 12(4):527-531
[7]Musa MD, Ateya HK.Prevalence of overt and occult hepatitis B virus infections among 135 haemodialysis patients attending a haemodialysis centre at Al-Nasiriyah city,Iraq[J].Iran J Microbiol, 2020, 12(5):475-482
[8] Kalantari H, Ferdowsi F, Yaran M.Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran[J].Adv Biomed Res, 2016, 5:151
[9]Sood AK, Pangotra C, Manrai M.Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital[J].Med J Armed Forces India, 2016, 72(2):140-144
[10]Muche M, Berg T, Rimpler S, et al.Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients[J].Liver international : official journal of the International Association for the Study of the Liver, 2019, 39(2):263-270
[11] Amer F, Yousif MM, Mohtady H, et al.Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection[J].Int J Infect Dis, 2020, 92:13-18
[12]Fontenele AMM, Gainer JBF, Da Silva E Silva DV, et al.Occult hepatitis B among patients with chronic renal failure on hemodialysis from a capital city in northeast Brazil[J].Hemodialysis international. International Symposium on Home Hemodialysis, 2015, 19(3):353-359
[13]Mandour M, Nemr N, Shehata A, et al.Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview[J].Revista da Sociedade Brasileira de Medicina Tropical, 2015, 48(3):258-264
[14]Esmail MA, Mahdi WK, Khairy RM, et al.Genotyping of occult hepatitis B virus infection in Egyptian hemodialysis patients without hepatitis C virus infection[J].J Infect Public Health, 2016, 9(4):452-457
[15]Mhalla S, Hammoud R, Frih A, et al.Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia[J].Medecine et maladies infectieuses, 2018, 48(3):175-179
[16]Abdel-Maksoud NHM, El-Shamy A, Fawzy M, et al.Hepatitis B variants among Egyptian patients undergoing hemodialysis[J].Microbiology and immunology, 2019, 63(2):77-84
[17]Katayama K, Sato T, Do SH, et al.Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence,incidence and occult hepatitis B virus infection[J].Hepatol Res, 2015, 45(12):1211-1219
[18] Sowole L, Labbett W, Patel M, et al.The prevalence of occult hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort[J].BMC Nephrol, 2015, 16(1)
[19]Tang Y, Liu X, Lu X, et al.Occult Hepatitis B Virus Infection in Maintenance Hemodialysis Patients: Prevalence and Mutations in "a" Determinant[J].Int J Med Sci, 2020, 17(15):2299-2305
[20]Rastegarvand N, Makvandi M, Samarbafzadeh A, et al.Molecular Characterization of Pre-CoreCore and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection[J].Jundishapur J Microbiol, 2015, 8(10)
[21]Msomi N, Ndlovu K, Giandhari J, et al.High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal,South Africa[J].Journal of medical virology, 2019, 91(10):1797-1803
[22]Ramezani A, Banifazl M, Eslamifar A, et al.Outcome of hemodialysis patients with occult hepatitis B virus infection at a 4 year follow-up[J].J Gastrointestin Liver Dis, 2013, 22(1):111-112
[23]Bernieh B.Viral hepatitis in hemodialysis: An update[J].J Transl Int Med, 2015, 3(3):93-105
[24]Mak L-Y, Wong DK-H, Pollicino T, et al.Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology,virology,hepatocarcinogenesis and clinical significance[J].Journal of hepatology, 2020, 73(4):952-964
[25]Waheed S, Philipneri M.Targeting Zero Infections in the Outpatient Dialysis Unit: Core Curriculum 2020[J].American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, 76(1):130-140
[26]Samadi E, Mirshahabi H, Motamed N, et al.Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients Using Nested PCR[J].Rep Biochem Mol Biol, 2020, 9(1):82-88
[27]常立阳, 张红梅.重视乙肝疫苗接种, 降低透析感染风险[J].中国血液净化, 2019, 18(12):858-860
[28]Yao T, Shao Z, Wu L, et al.Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China[J].Vaccine, 2021, 39(18):2537-2544
[29]Awad AM, Ntoso A, Connaire JJ, et al.An open-label,single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis[J].Vaccine, 2021, 39(25):3346-3352
[30]Hung IF, Yap DY, Yip TP, et al.A Double-blind,Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod,in Patients on Dialysis[J].Clin Infect Dis, 2021, 73(2):e304-e311
[31]Holt SG, Locarnini S, Sasadeusz J.Hepatitis B related dilemmas in the renal unit[J].Nephrology (Carlton, Vic.), 2021, 26(4):287-293
